Dexcom Inc
General
Total Cases75
Active Cases21
Patents894
Ratings
Experience
Grade
Trend
DCT
L1
C
PTAB
L5
A
CAFC
L2
D
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 09/19/24 | NOTICE OF SERVICE of 1. Defendant Dexcom, Inc.'s Response to Plaintiffs' Second Set of Requests for Production of Documents (Nos. 143 - 168) 2. Defendant and Counterclaim-Plaintiff Dexcom, Inc.'s Objections and Responses to Plaintiffs' Third Set of Interrogatories (26 - 43) 3. Defendant DexCom, Inc.'s Final Invalidity Contentions filed by DexCom, Inc..(DiBenedetto, Emily) (Entered: 09/19/2024) | |
| 09/19/24 | NOTICE OF SERVICE of Abbott's Objections and Responses to Dexcom's Third Set of Interrogatories (Nos. 28-47) filed by Abbott Diabetes Care Inc., Abbott Diabetes Care Limited.(Raucci, Anthony) (Entered: 09/19/2024) | |
| 09/19/24 | STIPULATION TO EXTEND TIME for the parties to (1) substantially complete custodial ESI production as set forth in the Stipulation and Order dated July 26, 2024 (D.I. 172) and (2) provide final responses to contention interrogatories as set forth in paragraph 4(d)(2) of the Courts Scheduling Order (D.I. 54) to October 24, 2024 and December 19, 2025, respectively - filed by Abbott Diabetes Care Inc., Abbott Diabetes Care Limited, Abbott Diabetes Care Sales Corp.. (Smith, Rodger) (Entered: 09/19/2024) | |
| 09/17/24 | NOTICE OF SERVICE of (1) Opening Expert Report of Paul Braun, Ph.D.; (2) Expert Report of Raeann Gifford, Ph.D.; (3) Expert Report of Professor David Hricik; (4) Expert Report of Bobak Mortazavi; (5) Opening Expert Report of Kevin W. Plaxco, Ph.D. Regarding Invalidity of U.S. Patent Nos. 11,000,213, 10,993,642, and 10,980,452; (6) Expert Report of Majid Sarrafzadeh, Ph.D. Regarding Invalidity of U.S. Patent No. 10,702,215; and (7) Expert Report of Matthew Schurman, Ph.D. Regarding Invalidity of U.S. Patent No. 10,980,452 filed by Abbott Diabetes Care Sales Corp., Abbott Diabetes Care, Inc..(Smith, Rodger) (Entered: 09/17/2024) | |
| 09/17/24 | NOTICE OF SERVICE of 1) Opening Expert Report of Bruce Gale, Ph.D. 2) Opening Expert Report of Ken Gall, Ph.D. 3) Opening Expert Report of Barry Keenan, Ph.D. 4) Expert Report of Patrick F. Kennedy, Ph.D. 5) Opening Expert Report of Lori Laffel, MD, MPH 6) Declaration of Seth James Nielson, Ph.D. 7) Expert Report of Jeffrey T. Prince, Ph.D. 8) Expert Report of Bryce M. Whited, Ph.D. filed by Dexcom, Inc..(DiBenedetto, Emily) (Entered: 09/17/2024) | |
| 09/17/24 | AMENDED ORDER: Oral argument on all pending motions for judgement as a matter of law in the above-captioned matter will be heard on October 8, 2024, beginning at 2:00 p.m. in the J. Caleb Boggs Federal Buildings, Wilmington, Delaware. Signed by Judge Kent A. Jordan on 9/16/2024. (jfm) (Entered: 09/17/2024) | |
| 09/16/24 | ORDER: Oral argument on defendant's pending motions for judgement as a matter of law in the above-captioned matter will be heard on October 8, 2024, beginning at 2:00 p.m. in the J. Caleb Boggs Federal Building, Wilmington, Delaware. Signed by Judge Kent A. Jordan on 9/16/2024. (jfm) (Entered: 09/16/2024) | |
| 09/13/24 | [SEALED] ANSWER to 15 Answer to Complaint,, Counterclaim,, Counter COUNTERCLAIM (Amended) against DexCom, Inc. by Abbott Diabetes Care Inc., Abbott Diabetes Care Limited. (Attachments: # 1 Exhibit A-F)(Smith, Rodger) (Entered: 09/13/2024) | |
| 09/13/24 | ORDER re 202 Unopposed MOTION for Leave to File Counterclaim Defendants' Answer to Dexcom's Counterclaims and Amended Counter-Counterclaims Under Rule 15(a)(2) filed by Abbott Diabetes Care Inc., Abbott Diabetes Care Limited. Signed by Judge Gregory B. Williams on 9/13/2024. (lnb) (Entered: 09/13/2024) | |
| 09/13/24 | Motions terminated: 201 STIPULATION TO EXTEND TIME to Respond to Amended Counter-Counterclaims to September 18, 2024 filed by DexCom, Inc. Signed by Judge Gregory B. Williams on 9/12/2024. (lnb) (Entered: 09/13/2024) |